AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $637,140 | -19.7% | 82,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $793,760 | +1.1% | 82,000 | +14.5% | 0.00% | 0.0% |
| Q1 2023 | $784,736 | +220.9% | 71,600 | +26.5% | 0.00% | +100.0% |
| Q4 2022 | $244,512 | +6.3% | 56,600 | +85.0% | 0.00% | -33.3% |
| Q3 2022 | $230,000 | -25.3% | 30,600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $308,000 | -4.3% | 30,600 | +17.7% | 0.00% | 0.0% |
| Q1 2022 | $322,000 | -8.0% | 26,000 | +69.9% | 0.00% | 0.0% |
| Q4 2021 | $350,000 | -52.1% | 15,300 | -53.7% | 0.00% | -50.0% |
| Q3 2021 | $731,000 | +70.8% | 33,037 | 0.0% | 0.01% | +50.0% |
| Q2 2021 | $428,000 | -0.2% | 33,037 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $429,000 | -60.6% | 33,037 | -58.0% | 0.00% | -25.0% |
| Q4 2020 | $1,088,000 | – | 78,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |